Haolin Liu, Pengcheng Wei, Qianqian Zhang, Zhongzhou Chen, Katja Aviszus, Walter Downing, . . . Gongyi Zhang. (2021). 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHaolin Liu, et al. 501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationHaolin Liu, et al. 501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.